Identification of p53 gene mutations in bladder cancers and urine samples.
about
Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe arrayTransforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variationsDigital PCRBiomarkers in monitoring for efficacy of immunotherapy and chemoprevention of bladder cancer with dimethylsulfoxideImmunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinomaGenetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screeningDISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m MutationEmerging molecular markers of cancer.Detection and quantification of rare mutations with massively parallel sequencing.Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancersMolecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.Biomarkers in environmental health research & practice.Molecular detection of minimal residual disease in colorectal and breast cancer.The genetics of transitional cell carcinoma: progress and potential clinical application.Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer.Molecular assessment of cancer.A rapid PCR ELISA for the detection of activated K-ras in colorectal cancer.microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer.P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.What we could do now: molecular pathology of bladder cancer.Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCRRelationship between schistosomiasis and bladder cancerDetection and quantification of mutations in the plasma of patients with colorectal tumors.Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.Applications of molecular diagnostics: solid tumor genetics can determine clinical treatment protocols.Lymph node micrometastases in head and neck cancer: a review.Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker.Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions.Molecular detection approaches for smoking associated tumors.An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer.The polymerase chain reaction: a tool for molecular medicine.Molecular biology of bladder cancer.The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers.A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.DNA methylation changes in prostate cancer: current developments and future clinical implementation.
P2860
Q24648335-96B079B8-6DDC-4DF1-9BAA-7CA867A47BDDQ24678861-E090A119-8BA3-41A5-A518-0927FFA647A8Q24685020-44A95586-4213-4E95-8977-6B2390A95DEFQ26343194-8A717AE1-A7DC-4C8F-9349-530776FDF999Q28139426-0047B555-76DB-4757-88A8-BD0EF35B0205Q28363010-05938E5C-7DBD-408F-96A4-D466297510E2Q28534155-6F6B9397-83B0-4ECE-ABA8-7285EEF10B5AQ30330271-2CE143C1-45AA-4832-A4A0-487A0E64233BQ30472217-8A44F641-5062-4D97-9FD7-0C52542F152EQ30499489-39A14ECB-B0C7-47B1-8DA4-C2D3FDF8E736Q31164021-EF6B1D42-544A-4836-8AD1-C63DCE665402Q33585904-070D3FE0-5ED3-4A69-9CE7-C6BC6864E87BQ33609814-25FE89CA-602A-41EF-BBC4-51052D4DF1A8Q33723575-0E05C0C6-BBCE-4733-BB5B-E08FBA44C50AQ33784739-50C0CA99-F9C7-4AAF-80DC-763A6EE38561Q33789916-3E55B80E-BFDC-4DD9-BB1E-B1A10852771FQ33838925-A326010A-06A7-4E96-93AB-C888DF426B25Q33853224-D0776EA5-FB02-4742-B76C-61AB44D0CB4AQ33899383-4FA60CBE-4AC8-4552-80AA-B12C162E825CQ33917646-A6999DE7-131E-45FD-8AE0-407A6AE26E8AQ33918737-BFBCB373-A572-459E-B04F-70B5F6E2389FQ33974374-8C10D36F-8C4C-4AA1-BBD1-517D6F53A809Q33975409-F54485E8-B6D7-447A-92ED-06A0B23F12C8Q34132363-CDF5FF7A-5152-4AB4-88E6-9F735F8B1D06Q34139666-A01184BF-1830-4614-9FC3-2C0830C9BF86Q34194269-82148209-5DB0-473C-B25E-F83A490D6196Q34418683-A65AED19-30BE-4063-AF41-B803B1798A3AQ34639833-DD36EAA8-1F2C-4B7C-A584-6BA0270BE4B9Q34674350-B90386B8-FDF4-4DF9-A517-156A9F4B1E97Q34810714-C02271AC-F015-40C5-8699-222D82F9EA55Q34844361-9CEFA0F6-103E-4414-B7D4-1B71E65AC9D6Q34936005-4960777D-29AC-4730-8BEE-F92BFE47BFE1Q34963422-A9168722-297E-420E-828F-86203A8D4808Q35091230-18A032F7-30A7-49AF-92D3-20A84F517B5EQ35147519-43294722-86DB-4E91-AD29-29C53B345F5EQ35186301-A4B8F915-39CD-4680-A890-8B551DB7F913Q35266400-C10C7ABA-DBC8-4827-BA9C-70038A15BEE7Q35367235-6E47A42D-C78D-4602-AAAB-D431374BF6EAQ35595377-C011CB8B-7F3E-4FDB-9806-294D400036FDQ35636543-0978EB6D-C415-46E7-8943-75E38F6BF25E
P2860
Identification of p53 gene mutations in bladder cancers and urine samples.
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Identification of p53 gene mutations in bladder cancers and urine samples.
@ast
Identification of p53 gene mutations in bladder cancers and urine samples.
@en
Identification of p53 gene mutations in bladder cancers and urine samples.
@nl
type
label
Identification of p53 gene mutations in bladder cancers and urine samples.
@ast
Identification of p53 gene mutations in bladder cancers and urine samples.
@en
Identification of p53 gene mutations in bladder cancers and urine samples.
@nl
prefLabel
Identification of p53 gene mutations in bladder cancers and urine samples.
@ast
Identification of p53 gene mutations in bladder cancers and urine samples.
@en
Identification of p53 gene mutations in bladder cancers and urine samples.
@nl
P2093
P356
P1433
P1476
Identification of p53 gene mutations in bladder cancers and urine samples.
@en
P2093
Hamilton SR
Marshall F
Sidransky D
Summerhayes I
Von Eschenbach A
P304
P356
10.1126/SCIENCE.2024123
P407
P577
1991-05-01T00:00:00Z